The Drug Enforcement Administration (DEA) received an application from Baxter Research Lab to register as a bulk manufacturer of marihuana, a Schedule I controlled substance. This registration would allow Baxter to produce large quantities of active pharmaceutical ingredients (APIs) for research purposes. The DEA will review the application to ensure all legal and safety measures are in place to prevent misuse. Comments or objections regarding this application can be submitted electronically until May 27, 2025.
Simple Explanation
The DEA is thinking about letting a company called Baxter Research Lab make a lot of a special plant called marihuana for scientific experiments, but only if they follow all the rules to keep it safe and not let it get into the wrong hands.